• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有复杂疾病儿童的多重用药情况:一项在儿科姑息治疗中心开展的横断面研究

Polypharmacy in Children with Medical Complexity: A Cross-Sectional Study in a Pediatric Palliative Care Center.

作者信息

Zanin Anna, Baratiri Fernando, Roverato Barbara, Mengato Daniele, Pivato Lisa, Avagnina Irene, Maghini Irene, Divisic Antuan, Rusalen Francesca, Agosto Caterina, Venturini Francesca, Benini Franca

机构信息

Palliative Care and Pain Service, Department of Women's and Children's Health, University of Padua, 35128 Padua, Italy.

Department of Women's and Children's Health, University of Padua, 35128 Padua, Italy.

出版信息

Children (Basel). 2024 Jul 4;11(7):821. doi: 10.3390/children11070821.

DOI:10.3390/children11070821
PMID:39062270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11274911/
Abstract

BACKGROUND

Children with medical complexity (CMC) often require multiple medications, leading to polypharmacy, which seems to be linked to adverse effects, administration errors, and increased caregiver burden. This study aimed to describe the prevalence of polypharmacy, medication burden, off-label drug use, and associated costs.

METHODS

Conducted at the Pediatric Palliative Care Center of Padua, Italy, from August to October 2021, this cross-sectional observational study included patients up to 23 years old with at least one prescribed drug. Data were collected from medical records and caregiver interviews. Drug costs were collected from the Italian Medicine Agency. Descriptive statistical analysis was performed. For comparisons among categorical variables, the Chi-square test was used, and for those among continuous variables, the ANOVA test was used.

RESULTS

This study analyzed treatment regimens of 169 patients with a median age of 12.5 years (0.3-23). Polypharmacy was present in 52.7% of patients, and medication burden was observed in 44.4%, both varying significantly by primary diagnosis ( < 0.001). The median daily cost per patient was EUR 2.2 (IQR 0.9-7.1), with significant variation among subgroups. Only 34.6% of prescriptions were off-label.

CONCLUSIONS

polypharmacy and medication burden are frequent among our CMC population, with some differences according to primary diagnosis.

摘要

背景

患有复杂疾病的儿童(CMC)通常需要多种药物治疗,这导致了多药联用,而多药联用似乎与不良反应、用药错误以及照顾者负担增加有关。本研究旨在描述多药联用的患病率、用药负担、超说明书用药情况及相关费用。

方法

本横断面观察性研究于2021年8月至10月在意大利帕多瓦的儿科姑息治疗中心进行,纳入了年龄在23岁及以下且至少开具了一种药物的患者。数据从病历和照顾者访谈中收集。药物费用从意大利药品管理局收集。进行描述性统计分析。对于分类变量之间的比较,使用卡方检验;对于连续变量之间的比较,使用方差分析。

结果

本研究分析了169例患者的治疗方案,患者中位年龄为12.5岁(0.3 - 23岁)。52.7%的患者存在多药联用情况,44.4%的患者存在用药负担,两者在不同的主要诊断中均有显著差异(<0.001)。每位患者的每日费用中位数为2.2欧元(四分位间距0.9 - 7.1),各亚组间存在显著差异。只有34.6%的处方为超说明书用药。

结论

在我们的CMC人群中,多药联用和用药负担很常见,且根据主要诊断存在一些差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/2e862ad14d86/children-11-00821-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/5ae0faf2b3ea/children-11-00821-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/cb8c48660139/children-11-00821-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/80a55a76fff6/children-11-00821-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/898109ff9616/children-11-00821-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/2e862ad14d86/children-11-00821-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/5ae0faf2b3ea/children-11-00821-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/cb8c48660139/children-11-00821-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/80a55a76fff6/children-11-00821-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/898109ff9616/children-11-00821-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d262/11274911/2e862ad14d86/children-11-00821-g006.jpg

相似文献

1
Polypharmacy in Children with Medical Complexity: A Cross-Sectional Study in a Pediatric Palliative Care Center.患有复杂疾病儿童的多重用药情况:一项在儿科姑息治疗中心开展的横断面研究
Children (Basel). 2024 Jul 4;11(7):821. doi: 10.3390/children11070821.
2
Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications.评估患者用药依从性、病历准确性以及处方药和非处方药的血药浓度。
JAMA Netw Open. 2018 Nov 2;1(7):e184196. doi: 10.1001/jamanetworkopen.2018.4196.
3
Identifying opportunities for pediatric medication therapy management in children with medical complexity.识别医疗复杂性儿童的儿科药物治疗管理机会。
J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1587-1595.e3. doi: 10.1016/j.japh.2022.04.005. Epub 2022 Apr 12.
4
Improving individualized prescription in patients with multimorbidity through medication review.通过药物审查改善多病共存患者的个体化处方。
BMC Geriatr. 2022 May 12;22(1):417. doi: 10.1186/s12877-022-03107-2.
5
Potentially inappropriate medication use among older adult patients on follow-up at the chronic care clinic of a specialized teaching hospital in Ethiopia. A cross-sectional study.在埃塞俄比亚一家专科医院的慢性病诊所接受随访的老年患者中潜在不适当的药物使用。一项横断面研究。
BMC Geriatr. 2021 Oct 7;21(1):530. doi: 10.1186/s12877-021-02463-9.
6
Polypharmacy among pediatric cancer patients dying in the hospital.儿科癌症住院死亡患者的多种药物治疗。
Isr Med Assoc J. 2021 Jul;23(7):426-431.
7
Exploring polypharmacy burden among elderly patients with chronic diseases in Chinese community: a cross-sectional study.探究中国社区慢性病老年患者的多重用药负担:一项横断面研究。
BMC Geriatr. 2021 May 13;21(1):308. doi: 10.1186/s12877-021-02247-1.
8
Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer.儿童癌症幸存者慢性处方药的使用及多重用药的患病率
Front Oncol. 2021 Apr 1;11:642544. doi: 10.3389/fonc.2021.642544. eCollection 2021.
9
The association between polypharmacy and medication regimen complexity and antibiotic use in bronchiectasis.支气管扩张症中多重用药与用药方案复杂性及抗生素使用之间的关联。
Int J Clin Pharm. 2018 Oct;40(5):1342-1348. doi: 10.1007/s11096-018-0681-1. Epub 2018 Jul 9.
10
Prevalence of polypharmacy and pharmacotherapy complexity in elderly people living with HIV in Spain. POINT study.西班牙老年HIV感染者多重用药及药物治疗复杂性的患病率。POINT研究。
Farm Hosp. 2020 Jul 1;44(4):127-134. doi: 10.7399/fh.11367.

引用本文的文献

1
Pre-prescription review system improves prescription safety, efficiency, and cost-effectiveness in pediatric outpatients: a western China study.预开方审核系统提高了儿科门诊患者处方的安全性、效率和成本效益:一项中国西部研究。
Front Pharmacol. 2025 Jul 24;16:1576442. doi: 10.3389/fphar.2025.1576442. eCollection 2025.
2
Assessment of Caregiver Burden and Burnout in Pediatric Palliative Care: A Path Toward Improving Children's Well-Being.儿科姑息治疗中照顾者负担与倦怠的评估:改善儿童福祉之路
Healthcare (Basel). 2025 Jul 2;13(13):1583. doi: 10.3390/healthcare13131583.
3
Alpha-2 agonists for refractory neurological symptoms in pediatric palliative care: a scoping review.

本文引用的文献

1
Polypharmacy-An Important Contributor to Health and Safety for Children With Medical Complexity: How Can We Improve Care for This Vulnerable Population?多重用药——医疗复杂儿童健康与安全的重要影响因素:我们如何改善对这一弱势群体的护理?
J Pediatr Pharmacol Ther. 2024 Apr;29(2):96-99. doi: 10.5863/1551-6776-29.2.96. Epub 2024 Apr 8.
2
Making Polypharmacy Safer for Children with Medical Complexity.使儿童药物治疗更加安全(为患有复杂疾病的儿童制定更安全的药物治疗方案)。
J Pediatr. 2023 Mar;254:4-10. doi: 10.1016/j.jpeds.2022.10.012. Epub 2022 Oct 15.
3
Polypharmacy in Children and Young People With Life-limiting Conditions From 2000 to 2015: A Repeated Cross-sectional Study in England.
α-2激动剂用于儿科姑息治疗中的难治性神经症状:一项范围综述
Front Pediatr. 2025 May 14;13:1542482. doi: 10.3389/fped.2025.1542482. eCollection 2025.
4
Improving Medication Safety Through Medication Reconciliation in Pediatric Neurology: Clinical Pharmacist Recommendations and Physician Uptake in a 13-Week Study.通过儿科神经科药物重整提高用药安全性:一项为期13周的研究中临床药师的建议及医生的采纳情况
Children (Basel). 2025 May 12;12(5):625. doi: 10.3390/children12050625.
5
Polypharmacy in Pediatric Palliative Care: Exploring Discrepancies Between Physicians and Pharmacists.儿科姑息治疗中的多药联用:探讨医生与药剂师之间的差异
Children (Basel). 2025 Jan 24;12(2):124. doi: 10.3390/children12020124.
6
The role and perception of the caregiver in a specialized pediatric palliative care center in medicine preparation and administration: a survey study.在医学准备和管理方面,专门的儿科姑息治疗中心中护理人员的角色和认知:一项调查研究。
Ital J Pediatr. 2024 Nov 6;50(1):238. doi: 10.1186/s13052-024-01809-4.
2000 年至 2015 年患有生命有限条件的儿童和青少年的多药治疗:英格兰的一项重复横断面研究。
J Pain Symptom Manage. 2022 Sep;64(3):213-221.e1. doi: 10.1016/j.jpainsymman.2022.05.020. Epub 2022 Jun 5.
4
Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review.住院儿童超适应证和无适应证用药的范围、原因和后果:叙述性综述。
World J Pediatr. 2021 Aug;17(4):341-354. doi: 10.1007/s12519-021-00430-3. Epub 2021 Jun 2.
5
The child with medical complexity.患有复杂疾病的儿童。
Ital J Pediatr. 2021 Jan 6;47(1):1. doi: 10.1186/s13052-020-00935-z.
6
Parent-Reported Symptoms and Medications Used Among Children With Severe Neurological Impairment.家长报告的患有严重神经功能障碍儿童的症状和使用的药物。
JAMA Netw Open. 2020 Dec 1;3(12):e2029082. doi: 10.1001/jamanetworkopen.2020.29082.
7
A Tool for the Evaluation of Clinical Needs and Eligibility to Pediatric Palliative Care: The Validation of the ACCAPED Scale.用于评估儿科姑息治疗临床需求和资格的工具:ACCAPED 量表的验证。
J Palliat Med. 2021 Feb;24(2):205-210. doi: 10.1089/jpm.2020.0148. Epub 2020 Jul 8.
8
Simplifying Medication Regimens for People Receiving Community-Based Home Care Services: Outcomes of a Non-Randomized Pilot and Feasibility Study.简化接受社区居家护理服务人群的药物治疗方案:一项非随机试点和可行性研究的结果。
Clin Interv Aging. 2020 Jun 2;15:797-809. doi: 10.2147/CIA.S248377. eCollection 2020.
9
Off-Label and Unlicensed Drugs in Pediatric Palliative Care: A Prospective Observational Study.儿科姑息治疗中的标签外用药和无许可证药物:一项前瞻性观察研究。
J Pain Symptom Manage. 2020 Nov;60(5):923-932. doi: 10.1016/j.jpainsymman.2020.06.014. Epub 2020 Jun 20.
10
Outcome measures in pediatric polypharmacy research: a scoping review.儿科多药联合治疗研究中的结局指标:一项范围综述
Drugs Ther Perspect. 2019 Sep;35(9):447-458. doi: 10.1007/s40267-019-00650-8. Epub 2019 Jul 12.